These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15077923)

  • 1. Prognostic value of cytokeratin 19 fragment (CYFRA 21-1) and cytokeratin-positive cells in bone marrow samples of breast cancer patients.
    Pierga JY; Deneux L; Bonneton C; Vincent-Salomon A; Nos C; Anract P; Magdelénat H; Pouillart P; Thiery JP
    Int J Biol Markers; 2004; 19(1):23-31. PubMed ID: 15077923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients.
    Pierga JY; Bonneton C; Vincent-Salomon A; de Cremoux P; Nos C; Blin N; Pouillart P; Thiery JP; Magdelénat H
    Clin Cancer Res; 2004 Feb; 10(4):1392-400. PubMed ID: 14977842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
    Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
    Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern.
    Effenberger KE; Borgen E; Eulenburg CZ; Bartkowiak K; Grosser A; Synnestvedt M; Kaaresen R; Brandt B; Nesland JM; Pantel K; Naume B
    Breast Cancer Res Treat; 2011 Feb; 125(3):729-38. PubMed ID: 20449649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.
    Thurm H; Ebel S; Kentenich C; Hemsen A; Riethdorf S; Coith C; Wallwiener D; Braun S; Oberhoff C; Jänicke F; Pantel K
    Clin Cancer Res; 2003 Jul; 9(7):2598-604. PubMed ID: 12855636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
    Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
    Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
    Pantel K; Schlimok G; Braun S; Kutter D; Lindemann F; Schaller G; Funke I; Izbicki JR; Riethmüller G
    J Natl Cancer Inst; 1993 Sep; 85(17):1419-24. PubMed ID: 7688814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Value of Serum CYFRA 21-1 and CK19-2G2 for Tumor Aggressiveness and Overall Survival in Hepatitis C-Related Hepatocellular Carcinoma Among Egyptians: A Prospective Study.
    Taher MY; Hassouna EM; El-Hadidi AS; El-Aassar OS; Bakosh MF
    J Gastrointest Cancer; 2024 Jun; 55(2):749-758. PubMed ID: 38231289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
    Pujol JL; Boher JM; Grenier J; Quantin X
    Lung Cancer; 2001; 31(2-3):221-31. PubMed ID: 11165401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    Braun S; Pantel K; Müller P; Janni W; Hepp F; Kentenich CR; Gastroph S; Wischnik A; Dimpfl T; Kindermann G; Riethmüller G; Schlimok G
    N Engl J Med; 2000 Feb; 342(8):525-33. PubMed ID: 10684910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytokeratin 19 expression in tumor tissue and serum CYFRA 21-1 levels in non-small cell lung cancer.
    Kosacka M; Jankowska R
    Pol Arch Med Wewn; 2009; 119(1-2):33-7. PubMed ID: 19341176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
    Nakata B; Ogawa Y; Ishikawa T; Ikeda K; Kato Y; Nishino H; Hirakawa K
    Cancer; 2000 Sep; 89(6):1285-90. PubMed ID: 11002224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Her2 expression on disseminated tumor cells from bone marrow of breast cancer patients.
    Becker S; Becker-Pergola G; Fehm T; Wallwiener D; Solomayer EF
    Anticancer Res; 2005; 25(3B):2171-5. PubMed ID: 16158960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cytokeratin-positive cells in bone marrow in breast cancer and colorectal carcinoma in comparison with other factors of prognosis.
    Leinung S; Würl P; Schönfelder A; Weiss CL; Röder I; Schönfelder M
    J Hematother Stem Cell Res; 2000 Dec; 9(6):905-11. PubMed ID: 11177604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
    Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
    J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
    Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
    Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA21-1) in human lung cancer cell lines.
    Dohmoto K; Hojo S; Fujita J; Yang Y; Ueda Y; Bandoh S; Yamaji Y; Ohtsuki Y; Dobashi N; Ishida T; Takahara J
    Int J Cancer; 2001 Feb; 91(4):468-73. PubMed ID: 11251967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance.
    Choesmel V; Pierga JY; Nos C; Vincent-Salomon A; Sigal-Zafrani B; Thiery JP; Blin N
    Breast Cancer Res; 2004; 6(5):R556-70. PubMed ID: 15318937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.